Wallstreetbets

The small cap space has been heating up recently, with random stocks popping 300% or more out of nowhere in one or a few days. There are three basic categories of stocks that are popping: 1. Low float/low volume multi-dollar stocks. 2. Penny stocks trading well below $0.50 and sometimes below $0.10  3. De-SPACs that have fallen way below their initial $10 merger value.  The stock that we are recommending to keep close watch on in the first category is  Greenwich LifeSciences, Inc. (GLSI) . It's a former major runner that went from $5.20 to $158 in one day in December 2020 after excellent data on its mid-stage breast cancer immunotherapy. The stock has been creeping up on low volume. It rose 20% on 156,000 volume last Wednesday and followed that up with another 11% gain on 89,000 volume on Friday. It picked up steam in the final hour, and if not for the early 1:00pm close, the stock might have broken out to $20.00. GLSI has 12.9 million shares outstanding, but only a 3.6 m...

Lightly traded, small float penny stocks have been on major runs this week. On Monday, FNHC was the big winner, running to as high as $0.69 from $0.12 the previous day. BTB and CNXA were the big winners on Tuesday, both running well in excess of 100%. On Wednesday, CRKN was the big winner, more than doubling at its high. Finally, today STAB was the one that doubled. FNGR has been on a multi-day run, leading to a 10-bagger for those who bought near the bottom. There is a commonality to all of these stocks. Other than their spike days, they are lightly traded, usually less than one million volume in a day, and had a major gap to fill.  One stock that makes an excellent candidate to be the next major penny stock spiker is PHAS. Particularly since STAB made a run today, so the trading opportunities are starting to head towards biotech. We saw a glimpse of what can happen as it shot up 10% in the last five minutes of trading today. PHAS has a major gap to fill from last week between $0....

Lightly traded, small float penny stocks have been on major runs recently. BTB and CNXA were up well over 100% during Tuesday's trading while FNHC went on a major run on Monday before it pulled back. FNGR has been on a major run of 1,000%. There is a commonality to all of these stocks. Other than their spike days, they are lightly traded, usually less than one million volume in a day, and had a major gap to fill.  One stock that makes an excellent candidate to be the next major penny stock spiker is PHAS. It has a major gap to fill from last week between $0.40 and $0.75: It tanked on bad news that its partner is trying to take the lead drug candidate for themselves, citing PHAS' weak financial state as the reason. Reading the 8-K filing , PHAS still has some legal premise to defend against its partner from taking the lead drug candidate for themselves so there's still hope/hype of recovery. The stock has cratered on light volume, with 6.6 million shares traded on the day af...

It was a crazy day for Atlis Motor Vehicles Inc (AMV). The stock opened up nearly 200% at $243.99 but closed at $75.15, down 8.5% on the day. It was another one of these small float IPO runners as the company did a $50 million Reg A raise of 1.85 million shares at $27.50.  Everyone is expecting the stock to collapse, however there is one stark difference between AMV and the other recent small float IPOs, which can be summarized in this chart below. It shows the price and volume of HKD, AXTG, MEGL, SHPH and AMV on their second and third day of listing, respectively. The thing that immediately stands out on AMV is its volume, or lack of it. 1.85 million shares are in the offering and only 230,000 of them traded today. The LESS volume one of these types of stocks have, the BETTER the chance that it has of going through the roof. By the third day of trading, AXTG and MEGL got pounded into submission with millions of shares traded. HKD traded just three million shares in these two days,...

There was carnage in the market today. Despite that, there were two stocks that bucked the trend and finished well into the green.  Stabilis Solutions, Inc. (SLNG) finished up 71% while  Winc, Inc. (WBEV) finished up 12%.  SLNG increased as heavily as it did because it announced that it has received authorization from the U.S. Department of Energy ("DOE") to export domestically produced liquefied natural gas ("LNG") to all free trade and non-free trade countries, including Asian, European, and Latin American importing nations. Under the DOE's order, Stabilis received authority to export on its own behalf, or as agent for others, up to the equivalent of 51.75 billion cubic feet per year of domestically produced LNG. The authorization is for a term of 28 years. While 71% is a nice move, we can't begin to explain how much of a game changer this is for SLNG. So we'll just show you one chart from the IEA which should clearly explain why this is so importa...

The best short squeezes aren't necessarily the ones with the highest short interest, but the ones that completely catch shorts by surprise. This is the case for AMLX. The company's drug AMX0035 is for the treatment of ALS, best known as Lou Gehrig's disease. Last week the drug got a 7 to 2 recommendation in favor of approval by the FDA's panel. With the PDUFA coming up on September 29, things are looking up for AMLX as the FDA generally votes in favor of panel recommendations. What makes this event a particular hit to shorts is that it came as a complete surprise. The recommendation by the committee is a reversal of opinion from the ruling in March. The stock actually tanked 23% on September 2 after initial FDA briefing documents pointed to a negative outcome. Short interest has been steadily rising over the last several months, and hit 3.4 million as of August 15. However, based on the price performance of September 2, this short interest has almost certainly continue...

BBBY touched as high as $30 yesterday but is getting crushed to the $17's in early trading this morning. As traders exit the position, they might be looking for the next possible squeeze runner candidate. GETY and FAZE make two ideal candidates. In fact, if BBBY holders who are hoping for $1,000 or some other very high target sold BBBY and placed the money into GETY or FAZE, they might actually get that type of target on those two stocks because the floats are so small, short interest is high and open interest on call options is large so gamma squeeze potential is there.  A quick background, repeated from our note from last week . GETY and FAZE are two recent de-SPAC listings. Both stocks merged with their SPAC listing at the height of the bear market. As such, they both had an extraordinarily high amount of redemptions as the SPAC investors were running for safety and taking the cash, thinking that both stocks would tank out of the gate like so many other SPACs have done over the ...